Bortezomib 63759-3032
Product NDC
63759-3032- Manufacturer
- Shilpa Medicare Limited
- Dosage Form
- Injection
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 25, 2024
- Listing Expires
- December 31, 2026
- Application
- NDA212782
Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bortezomib | 3.5 mg/1.4mL |
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (63759-3032-1) / 1.4 mL in 1 VIAL, SINGLE-DOSE